Release from alginate enhances the biological activity of vascular endothelial growth factor.
A primary factor which limits engineering tissues of substantial size is the lack of nutrients readily available to transplanted cells. One potential solution to this nutrient limitation is to encourage the rapid development of a vascular network within three-dimensional tissue engineering matrices. Vascular endothelial growth factor (VEGF) has been identified as a potent stimulator of angiogenesis in vivo. Though effective at stimulating endothelial cells to form blood vessels VEGF degrades rapidly. Spherical alginate beads (3.3+/-0.1 mm diameter) were examined as a means of delivering biologically functional VEGF at a controlled rate over extended times. The alginate beads demonstrated the ability to incorporate VEGF with an efficiency between 30 and 67%, depending on the processing conditions, and release it at a constant rate (5%/day) for up to 14 days in vitro. The released VEGF, when assayed for its ability to stimulate endothelial cells in culture, was found not only to be functional but more potent (three to five times) than the same mass of VEGF added directly to the culture medium. The release kinetics of freeze dried VEGF containing alginate beads were also examined and found to be comparable to non-freeze dried samples.
Peters
M C
MC
Department of Biomedical Engineering, University of Michigan, Ann Arbor 48109-2136, USA.
Isenberg
B C
BC
Rowley
J A
JA
Mooney
D J
DJ
D000464:Alginates / Q000737:chemistry / Q000494:pharmacology*; D002452:Cell Count; D017690:Cell Transplantation; D002478:Cells, Cultured; D016503:Drug Delivery Systems / Q000379:methods; D016228:Endothelial Growth Factors / Q000008:administration & dosage / Q000494:pharmacology*; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects*; D006801:Humans; D020100:Hydrogels / Q000494:pharmacology; D008222:Lymphokines / Q000008:administration & dosage / Q000494:pharmacology*; D008863:Microspheres; D018919:Neovascularization, Physiologic / Q000187:drug effects; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D000464:Alginates; D016228:Endothelial Growth Factors; D020100:Hydrogels; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors